Skip to content

Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.

Molecular Neurobiology July 28, 2026 DOI: 10.1007/s12035-026-06086-2 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Topics Esketamine Ketamine
Key points Argues that biomarkers of bipolar disorder progression could be used to guide ketamine and psychedelic interventions, potentially improving treatment personalization and outcomes, though further research is needed.

Abstract

Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.

Comparable studies

Other theoretical and historical papers on ketamine, most cited first.

Citations in the library

Explore topics